Roivant Sciences Ltd (87S) Stock Price & News

Symbols Symbols	Price	Change	% Change	Trend	Prev Close	ખોલો	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB -0.21%	1,091.51	-2.30	-0.21%	—	1,093.81	1,096.52	1,100.22	1,091.51	—	—
SIXC Communications SIXC Communications	SIXC +0.22%	610.11	+1.34	+0.22%	—	608.77	608.77	612.97	608.77	—	—
SIXE Energy SIXE Energy	SIXE -1.34%	1,237.98	-16.83	-1.34%	—	1,254.81	1,253.01	1,253.87	1,226.33	—	—
SIXI Industrials SIXI Industrials	SIXI -0.93%	1,744.71	-16.40	-0.93%	—	1,761.11	1,764.27	1,766.88	1,744.71	—	—
SIXM Financials SIXM Financials	SIXM -0.37%	640.18	-2.40	-0.37%	—	642.58	644.87	648.48	640.18	—	—
SIXR Staples SIXR Staples	SIXR -0.18%	849.58	-1.55	-0.18%	—	851.13	855.66	858.75	845.56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0.23%	217.48	-0.50	-0.23%	—	217.98	217.98	218.65	216.88	—	—
SIXT Technology SIXT Technology	SIXT +1.52%	3,260.69	+48.86	+1.52%	—	3,211.83	3,227.21	3,268.38	3,226.55	—	—
SIXU Utilities SIXU Utilities	SIXU -0.69%	942.45	-6.53	-0.69%	—	948.98	948.58	957.83	941.97	—	—
SIXV Health care SIXV Health care	SIXV -0.52%	1,466.80	-7.72	-0.52%	—	1,474.52	1,479.03	1,481.04	1,466.80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0.22%	2,397.50	+5.38	+0.22%	—	2,392.12	2,396.95	2,421.22	2,382.32	—	—

87S:FRA

Roivant Sciences Ltd

€23.54

+0.26%

(+0.060) 1D

30 એપ્રિલ, 10:00:00 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 87S...

ખોલો

€23.16

High

€23.54

Low

€23.16

Mkt. cap

૧૯.૯૨ અબજ

Avg. vol.

૬.૦૦

Volume

૦.૦૦

52-wk high

€25.72

52-wk low

€8.98

No. of employees

૭૫૦

News stories

From sources across the web

Seeking Alpha

3 દિવસ પહેલાં

Roivant Sciences: Moderna Settlement, Brepocitinib Support A Long-Term Buy (NASDAQ:ROIV)

પ્રોફાઇલ

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia

About Roivant Sciences Ltd

CEOમૅટ ગ્લીન

Employees750

Founded7 એપ્રિલ, 2014

Headquarters-

Sector-

Websiteroivant.com

All values in USD	માર્ચ 2025	જૂન 2025	સપ્ટે 2025	ડિસે 2025
Revenue	75.70 લાખ	21.70 લાખ	15.71 લાખ	19.99 લાખ
Cost of goods sold	14.50 કરોડ	15.26 કરોડ	16.42 કરોડ	16.61 કરોડ
Cost of revenue	14.50 કરોડ	15.26 કરોડ	16.42 કરોડ	16.61 કરોડ
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	22.77 કરોડ	12.82 કરોડ	12.95 કરોડ	17.51 કરોડ
Operating expense	22.77 કરોડ	12.82 કરોડ	12.95 કરોડ	17.51 કરોડ
Total operating expenses	37.27 કરોડ	28.08 કરોડ	29.37 કરોડ	34.11 કરોડ
Operating income	-36.52 કરોડ	-27.86 કરોડ	-29.21 કરોડ	-33.91 કરોડ
Other non operating income	1.13 કરોડ	-1.35 કરોડ	-2.67 કરોડ	-1.61 કરોડ
EBT including unusual items	-20.31 કરોડ	-26.93 કરોડ	-15.90 કરોડ	-29.04 કરોડ
EBT excluding unusual items	-29.93 કરોડ	-24.38 કરોડ	-27.34 કરોડ	-31.19 કરોડ
Income tax expense	4.93 કરોડ	46.49 લાખ	69.95 લાખ	2.33 કરોડ
Effective tax rate	-24.29%	-1.73%	-4.40%	-8.04%
Other operating expenses	-	-	-	-
Net income	-20.65 કરોડ	-22.34 કરોડ	-11.35 કરોડ	-26.59 કરોડ
Net profit margin	-2,727.54%	-10,292.86%	-7,225.91%	-13,301.20%
Earnings per share	-0.22	-0.25	-0.28	-0.24
Interest and investment income	5.46 કરોડ	4.83 કરોડ	4.53 કરોડ	4.33 કરોડ
Interest expense	-	-	-	-
Net interest expenses	5.46 કરોડ	4.83 કરોડ	4.53 કરોડ	4.33 કરોડ
Depreciation and amortization charges	-	-	-	-
EBITDA	-35.70 કરોડ	-27.75 કરોડ	-29.12 કરોડ	-33.84 કરોડ
Gain or loss from assets sale	-31.08 લાખ	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research